Medicine and Dentistry
Malignant Neoplasm
87%
B Cell
68%
Immunotherapy
63%
Neoplasm
63%
Treatment Response
62%
Lymphocyte
55%
Immune Checkpoint Inhibitor
55%
Immune Checkpoint Blockade
52%
Microbiome
51%
Melanoma
50%
Cytoreductive Surgery
49%
Cancer
45%
Targeted Therapy
44%
Double-Strand DNA Break
41%
Diseases
38%
Adenocarcinoma
36%
DNA Damage Response
36%
Androgen Receptor
36%
Receptor Blocking
36%
Surgeon
35%
Gut
32%
Cancer Therapy
32%
DNA Damage
31%
Medicine
30%
Probiotics
30%
Recurrent Disease
26%
Lymphocyte Development
25%
Peritoneum Metastasis
24%
Immunity
23%
Ionizing Radiation
23%
CA 19-9 Antigen
18%
Glioblastoma
18%
Vedolizumab
18%
Immune-Related Adverse Events
18%
Tumor Immune Microenvironment
18%
Patient Referral
18%
Colitis
18%
Gut Microbiome
18%
Ulcerative Colitis
18%
Fecal Microbiota Transplantation
18%
Appendix Tumor
18%
Division
18%
Precancerous Condition
18%
DNA Cleavage
18%
Next Generation Sequencing
18%
Tertiary Lymphoid Structure
18%
Colectomy
18%
Carcinoembryonic Antigen
18%
Colon Carcinoma
18%
Cancer Treatment
18%
Keyphrases
Lymphocytes
100%
DNA Double-strand Breaks
90%
Microbiome
55%
H2AX
55%
V(D)J Recombination
55%
Gut Microbiome
46%
Immune Checkpoint Inhibitors
46%
G1 Phase
44%
Cytoreductive Surgery
42%
Antigen Receptor Loci
42%
DNA Damage Response
41%
Therapeutic Response
38%
Androgen Receptor Blockade
36%
Colitis
36%
Fecal Microbiota Transplantation
36%
Macrophages
36%
Phosphocholine Cytidylyltransferase
36%
Appendiceal Adenocarcinoma
36%
Targeted Therapy
36%
DNA Damage
34%
Melanoma
33%
Resection
33%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
30%
Endonuclease
29%
Ataxia Telangiectasia mutated
28%
Immune Checkpoint Blockade
27%
Microbes
27%
Lymphocyte Development
25%
Peritoneal Metastasis
24%
Genotoxic Damage
23%
Tumor Growth
23%
Cancer Therapy
23%
Transcriptional Response
23%
53BP1
23%
Ionizing Radiation
23%
Murine Lymphocytes
22%
LYVE-1
22%
Neoadjuvant
21%
Pre-B Cells
21%
DNA Cleavage
21%
DNA End Resection
21%
CtIP
21%
Treatment Strategy
21%
Chromosomal Translocation
21%
Tumor
20%
Oncology
18%
Lazar
18%
Secondary Cytoreductive Surgery
18%
Lysine
18%
5-bisphosphate
18%
Immunology and Microbiology
Lymphocyte
98%
Microbiome
80%
Double-Strand DNA Break
75%
B Cell
68%
Macrophage
55%
Immunity
54%
Microorganism
46%
Cell Cycle G1 Phase
43%
Gut Microbiome
40%
DNA Damage Response
40%
Immune Checkpoint Blockade
37%
Cancer Immunotherapy
36%
Microflora
31%
DNA Damage
31%
Immunotherapy
30%
Maximum Reaction Velocity
27%
Receptor Gene
26%
Lymphocyte Development
25%
DNA Cleavage
23%
DNA End Joining Repair
21%
V(D)J Recombination
21%
Mesothelium
18%
Vedolizumab
18%
Amino Acid
18%
Feces microflora
18%
Dendritic Cell
18%
Myeloid
18%
Lysine
18%
Colitis
18%
Tumor Immunity
18%
Omentum
18%
Drosophila melanogaster
18%
Arginine
18%
Tertiary Lymphoid Structure
18%
Transcription Intermediary Factor 1 Beta
18%
Cancer Immunology
18%
Gut-Associated Lymphoid Tissue
18%
Ulcerative Colitis
18%
Cell Function
17%
Ataxia Telangiectasia
13%
Nuclease
13%
Recombination-Activating Gene
13%
Baculovirus Expression System
12%
Cell Cycle
12%
Threonine
12%
Serine
12%
Wild Type
9%
T Cell Receptor
9%
Cell Maturation
9%
Cell Transformation
9%